R.PR
REGISTERED-PRINCIPAL REGISTER
02/08/2022
Back to search
Official data from USPTO
EXCELLTHERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXCELLTHERA
ST13
US500000088167461Class
5, 42
Filing
88167461
Registration
6639560
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/29/2022
Trademark type
Word
Nice classes
5, 42
Filing date
10/24/2018
Registration date
02/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/08/2022
Last transaction
04/29/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
06/25/2021
First use in commerce
06/25/2021
Drawing code
4
Owner type
03
Owner location
Montreal, Quebec, CA
Examiner
PINO, DOMINIC ROBERT
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ExcellThera Inc.
Representatives
Ernest V. Linek BANNER & WITCOFF, LTD.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations in the nature of stem cells solutions to enable stem cell expansion for therapeutic purposesused in hematopoietic stem cell transplantation (HSCT) for patients with blood cancers; Bioengineering pharmaceutical solutions containing small molecules for use in expanding cells for therapeutic use to patients with blood cancers and other diseases
Class 42
Medical and scientific research in the field of stem cells; medical laboratory research; medical and scientific researchconducting pre-clinical and clinical trials for others
Publications
History of USPTO decisions and trademark events.
38 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/05/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/04/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/04/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/04/2022
IUAF
USE AMENDMENT FILED
12/10/2021
EISU
TEAS STATEMENT OF USE RECEIVED
12/10/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/03/2021
EX4G
SOU EXTENSION 4 GRANTED
06/01/2021
EXT4
SOU EXTENSION 4 FILED
06/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/01/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/25/2020
EX3G
SOU EXTENSION 3 GRANTED
11/23/2020
EXT3
SOU EXTENSION 3 FILED
11/23/2020
EEXT
SOU TEAS EXTENSION RECEIVED
11/23/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/16/2020
EX2G
SOU EXTENSION 2 GRANTED
05/14/2020
EXT2
SOU EXTENSION 2 FILED
05/14/2020
EEXT
SOU TEAS EXTENSION RECEIVED
05/14/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/18/2019
EX1G
SOU EXTENSION 1 GRANTED
12/16/2019
EXT1
SOU EXTENSION 1 FILED
12/16/2019
EEXT
SOU TEAS EXTENSION RECEIVED
12/16/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/18/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/23/2019
PUBO
PUBLISHED FOR OPPOSITION
04/23/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
03/19/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
03/15/2019
ALIE
ASSIGNED TO LIE
03/04/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
02/13/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/13/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
02/13/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/13/2019
DOCK
ASSIGNED TO EXAMINER
01/31/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/06/2018
NWAP
NEW APPLICATION ENTERED
10/27/2018
Continuous trademark protection
Get notified about every new filing that threatens EXCELLTHERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.